16
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Presence of Interleukin 4 or Interleukin 10, but Not Both Cytokines, in Pancreatic Tissue of Two Patients with Recently Diagnosed Diabetes Mellitus Type I

, , , &
Pages 161-166 | Received 11 Feb 2000, Accepted 03 Apr 2000, Published online: 07 Jul 2009

References

  • Liblau R S, Singer S M, McDevitt H. O. Th 1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995; 16: 34–8
  • Kallman B A, Huther M, Tubes M., et al. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes 1997; 46: 237–43
  • Ng W Y, Thai A C, Lui K F, Yeo P P, Cheah J. S. Systemic levels of cytokines and GAD-specific autoantibodies isotypes in Chinese IDDM patients. Diabetes Res. Clin. Pract 1999; 43: 127–35
  • Rapoport M J, Mor A, Vardi P., et al. Decreased secretion of Th2 cytokines precedes Up-regulated and delayed secretion of Thl cytokines in activated peripheral blood mononuclear cells from patients with insulin-dependent diabetes mellitus. J Autoimmun 1998; 11: 635–42
  • Somoza N, Vargas F, Roura-Mir C., et al. Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V (5 usage and cytokine profile. J. Immunol 1994; 153: 1360–77
  • Yamagata K, Nakajima H, Tomita K., et al. Dominant TCR alpha-chain clonotypes and interferon-gamma are expressed in the pancreas of patients with recent-onset insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract 1996; 34: 37–46
  • Huang X, Yuang J, Goddard A., et al. Interferon expression in the pancreases of patients with type I diabetes. Diabetes 1995; 44: 658–64
  • Chou Q, Russell M, Birch D E, Raymond J, Bloch W. Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications. Nucl. Acids Res. 1992; 20: 1717–23
  • Butch A W, Chung G H, Hoffman J W, Nahm M. H. Cytokine expression by germinal center cells. J. Immunol 1993; 150: 39–47
  • Yamamura M, Uyemura K, Deans R. J., et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254: 277–9
  • Arai N, Nomura D, Villaret D., et al. Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression. J Immunol 1989; 142: 274–82
  • Vieira P, Waal-Malefyt R, Dang M. N., et al. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc. Natl. Acad. Sci. U. S. A 1991; 88: 1172–6
  • Devos R, Cheroutre H, Taya Y, Degrave W, Van Heuverswyn H, Fiers W. Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells. Nucleic Acids Res 1982; 10: 2487–501
  • Emi M, Nakamura Y, Ogawa M., et al. Cloning, characterization and nucleotide sequences of two cDNAs encoding human pancreatic trypsinogens. Gene 1986; 41: 305–10
  • Almawi W Y, Tamim H, Azar S. T. Clinical review 103: T helper type 1 and 2 cytokines mediate the onset and progression of type I (insulin-dependent) diabetes. J Clin. Endocrinol. Metab 1999; 84: 1497–502
  • Rapoport M J, Jaramillo A, Zipris D., et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp. Med. 1993; 178: 87–99
  • Wogensen L, Lee M S, Sarvetnick N. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice. J Exp. Med. 1994; 179: 1379–84
  • Faust A, Rothe H, Schade U, Lampeter E, Kolb H. Primary nonfunction of islet grafts in autoimmune diabetic nonobese diabetic mice is prevented by treatment with interleukin-4 and interleukin-10. Transplantation 1996; 62: 648–52
  • Berman M A, Sandborg C I, Wang Z., et al. Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus. J Immunol 1996; 157: 4690–6
  • Del Prete G, De Carli M, Almerigogna F, Giudizi M G, Biagi-Otti R., Romagnani S. Human IL-10 is produced by both Type 1 helper (Thl) and Type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol 1993; 150: 353–60
  • Szelachowska M, Kretowski A, Kinalska I. Decreased in vitro IL-4 and IL-10 production by peripheral blood in first degree relatives at high risk of diabetes type-I. Harm. Metab Res. 1998; 30: 526–30

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.